• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PSMA 靶向配体的合成及初步体外评价,其赖氨酸 ε-氮原子上具有修饰的芳基部分。

Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom.

机构信息

Lomonosov Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.

Lomonosov Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.

出版信息

Bioorg Med Chem Lett. 2022 Sep 1;71:128840. doi: 10.1016/j.bmcl.2022.128840. Epub 2022 May 31.

DOI:10.1016/j.bmcl.2022.128840
PMID:35661685
Abstract

We report an improved series of ligands targeting prostate specific membrane antigen (PSMA). The new compounds were designed by the introduction of changes in the structure of the aromatic fragment at ε-nitrogen atom of lysine that resulted in improved biological parameters. Some of them demonstrated high selectivity and nanomolar IC values. We synthesized and tested two conjugates with a fluorescent label Sulfo-Cy5 as an example of the use of the obtained PSMA inhibitors as a basis for the creation of diagnostic preparations.

摘要

我们报告了一系列针对前列腺特异性膜抗原(PSMA)的改良配体。新化合物的设计是通过改变赖氨酸ε-氮原子上芳环片段的结构来实现的,这导致了生物参数的改善。其中一些化合物表现出高选择性和纳摩尔 IC 值。我们合成并测试了两种带有荧光标记 Sulfo-Cy5 的缀合物,以此为例,使用所获得的 PSMA 抑制剂作为创建诊断制剂的基础。

相似文献

1
Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom.PSMA 靶向配体的合成及初步体外评价,其赖氨酸 ε-氮原子上具有修饰的芳基部分。
Bioorg Med Chem Lett. 2022 Sep 1;71:128840. doi: 10.1016/j.bmcl.2022.128840. Epub 2022 May 31.
2
Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer.多功能荧光抑制剂的合成与评价及其与前列腺特异性膜抗原和缺氧的协同作用用于前列腺癌。
Bioconjug Chem. 2019 Jan 16;30(1):90-100. doi: 10.1021/acs.bioconjchem.8b00767. Epub 2018 Dec 11.
3
Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them.基于芳香残基的 PSMA 配体的合成及生物评价和荧光共轭物。
J Med Chem. 2021 Apr 22;64(8):4532-4552. doi: 10.1021/acs.jmedchem.0c01935. Epub 2021 Apr 6.
4
Synthesis of Prostate-Specific Membrane Antigen-Targeted Bimodal Conjugates of Cytotoxic Agents and Antiandrogens and Their Comparative Assessment with Monoconjugates.前列腺特异性膜抗原靶向细胞毒药物和抗雄激素双模态缀合物的合成及其与单缀合物的比较评估。
Int J Mol Sci. 2023 Jul 11;24(14):11327. doi: 10.3390/ijms241411327.
5
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.具有对前列腺癌的两种不同生物标志物(胃泌素释放肽受体/前列腺特异性膜抗原)亲和力的新型二价靶向载体——铜-64放射性标记的[DUPA-6-氨基己酸-(NODAGA)-5-氨基戊酸-蛙皮素(7-14)NH2]的合成与生物学评价
Nucl Med Biol. 2014 Apr;41(4):355-63. doi: 10.1016/j.nucmedbio.2014.01.001. Epub 2014 Jan 10.
6
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of Ga, In, Lu and Ac.评估携带新型螯合物的PSMA靶向配体在诊疗学中的应用:镓、铟、镥和锕的稳定性及络合动力学
Nucl Med Biol. 2017 Dec;55:38-46. doi: 10.1016/j.nucmedbio.2017.10.001. Epub 2017 Oct 3.
7
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.含硼前列腺特异性膜抗原配体的合成及初步生物学评价用于硼中子俘获治疗前列腺癌。
Mol Pharm. 2019 Sep 3;16(9):3831-3841. doi: 10.1021/acs.molpharmaceut.9b00464. Epub 2019 Aug 16.
8
Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.基于花青骨架的靶向前列腺特异性膜抗原的杂化示踪剂:调节药代动力学性质和探索染料-蛋白相互作用。
J Nucl Med. 2020 Feb;61(2):234-241. doi: 10.2967/jnumed.119.233064. Epub 2019 Sep 3.
9
Synthesis and preliminary evaluation of prostate-specific membrane antigen targeted upconversion nanoparticles as a first step towards radio/fluorescence-guided surgery of prostate cancer.前列腺特异性膜抗原靶向性上转换纳米粒子的合成与初步评价:迈向前列腺癌放射/荧光引导手术的第一步
J Mater Chem B. 2021 Sep 22;9(36):7423-7434. doi: 10.1039/d1tb00777g.
10
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.99mTc 标记的前列腺特异性膜抗原小分子抑制剂用于前列腺癌的分子成像。
J Nucl Med. 2013 Aug;54(8):1369-76. doi: 10.2967/jnumed.112.116624. Epub 2013 Jun 3.

引用本文的文献

1
Synthesis and Preclinical Evaluation of Urea-Based Prostate-Specific Membrane Antigen-Targeted Conjugates Labeled with Lu.基于尿素的前列腺特异性膜抗原靶向共轭物(用镥标记)的合成与临床前评估。
ACS Pharmacol Transl Sci. 2024 May 1;7(5):1457-1473. doi: 10.1021/acsptsci.4c00070. eCollection 2024 May 10.
2
Synthesis, I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures.新型基于尿素的 PSMA 抑制剂的合成、I-放射性标记优化及初步临床前评价,其结构中含有三丁基锡基拟肽基团。
Int J Mol Sci. 2023 Jul 30;24(15):12206. doi: 10.3390/ijms241512206.
3
Synthesis of Prostate-Specific Membrane Antigen-Targeted Bimodal Conjugates of Cytotoxic Agents and Antiandrogens and Their Comparative Assessment with Monoconjugates.
前列腺特异性膜抗原靶向细胞毒药物和抗雄激素双模态缀合物的合成及其与单缀合物的比较评估。
Int J Mol Sci. 2023 Jul 11;24(14):11327. doi: 10.3390/ijms241411327.